|
|
|
|
| LEADER |
01325nam a2200325 i 4500 |
| 001 |
c000321305 |
| 003 |
CARM |
| 005 |
00000000000000.0 |
| 008 |
760107s1975 dcu b 00010 eng |
| 019 |
1 |
|
|a 391814
|5 LACONCORD2021
|
| 020 |
|
|
|a 0844731676 :
|c $3.50
|
| 035 |
|
|
|a (OCoLC)1682059
|5 LACONCORD2021
|
| 043 |
|
|
|a n-us---
|
| 050 |
0 |
0 |
|a RS122
|b .W37
|
| 100 |
1 |
|
|a Wardell, William M.
|
| 245 |
1 |
0 |
|a Regulation and drug development /
|c William M. Wardell and Louis Lasagna.
|
| 260 |
|
|
|a Washington :
|b American Enterprise Institute for Public Policy Research,
|c 1975.
|
| 300 |
|
|
|a 181 p. ;
|c 23 cm.
|
| 490 |
0 |
|
|a Evaluative studies ; 21
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Drugs
|x Research
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical policy
|z United States.
|
| 700 |
1 |
|
|a Lasagna, Louis,
|d 1923-
|e joint author.
|
| 810 |
2 |
|
|a American Enterprise Institute for Public Policy Research.
|t Evaluative studies ;
|v 21.
|
| 852 |
8 |
|
|b CARM
|h A1:AN33B0
|i B08972
|p 0420928
|f BK
|
| 082 |
0 |
4 |
|a 615/.1/072073
|
| 999 |
f |
f |
|i 928882b8-77d9-5855-a03b-34b083f38df1
|s ab8ade4e-b0b4-568d-ac05-f8e7792e5ca5
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|e B08972
|f A1:AN33B0
|h Other scheme
|i book
|m 0420928
|